05 Sep 2023 The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain Member news
04 Sep 2023 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus Member news
01 Sep 2023 SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure Member news
29 Aug 2023 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus Member news
28 Aug 2023 Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders Member news
21 Aug 2023 ENOUGH raises €40M growth funding co-led by World Fund and CPT to scale up production Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
